Skip to main content
. 2021 Jun 9;12(1):2499–2510. doi: 10.1080/21655979.2021.1936891

Figure 4.

Figure 4.

Targeting the miR-6734-3p/ZEB2 axis hampered cancer progression in NSCLC. (a, b) CCK-8 assay and (c) colony formation assay was used to evaluated cell growth in vitro. Cell mobility was evaluated by using the (d) Transwell assay and (e) wound scratch assay. (f, g) The protein levels of EMT associated signatures were determined by Western Blot. (h) Cell apoptosis ratio in NSCLC cells was measured by FCM assay. Individual experiment had 3 repetitions, and *P < 0.05